79 w main partners LLC

121 cedar ave
islip, new york 11751

NYS Entity Status
ACTIVE

NYS Filing Date
JULY 25, 2014

NYS DOS ID#
4612319

County
SUFFOLK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2014 - 79 W MAIN PARTNERS LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • The Gang Murders in the Suburbs
    By LIZ ROBBINS and NADIA T. RODRIGUEZ - Wednesday Jul 12, 2017

    Four young Latino men went to hang out in the woods on Long Island one night during spring break. They ended up victims of the brutal gang MS-13.

    Source: NYT > Home Page
  • Near The East River, Plans Emerge For NY’s Next Life Science Center
    By Ben Fidler - Monday Aug 21, 2017

    At a time when biotech incubators and shared spaces are beginning to multiply in Manhattan, work on what could rank among the city’s largest biotech centers—if it can all come together—is just getting underway. According to Paul Wexler, a longtime healthcare-focused real estate broker, construction should begin next year on what is being called the […]

    Source: Xconomy New York
  • Rooted in Counterculture, Whole Foods’ Founder Finds an Unlikely Refuge
    By MICHAEL J. de la MERCED and ALEXANDRA STEVENSON - Friday Jun 16, 2017

    John Mackey wanted to fight off the activist investors attacking Whole Foods. He found a savior in Amazon, a company blamed for laying waste to retailers.

    Source: NYT > Home Page
  • Third Point, a Hedge Fund, Sets Its Activist Sights on Nestlé
    By MICHAEL J. de la MERCED - Sunday Jun 25, 2017

    The fund, run by Daniel S. Loeb, has called on the Swiss food giant to sell its stake in L’Oréal and move more quickly to adapt to changing consumer tastes.

    Source: NYT > Home Page
  • For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY
    By Ben Fidler - Wednesday Aug 9, 2017

    A drug that actually slows or reverses the brain damage inflicted by Parkinson’s disease, rather than just alleviates its often debilitating symptoms, remains elusive. But Prevail Therapeutics, a startup just launched in New York, has become the latest to try. This morning, the Silverstein Foundation, a nonprofit organization formed by OrbiMed partner Jonathan Silverstein, announced […]

    Source: Xconomy New York
79 w main partners llc islip ny